NCT02488330 2019-07-23An Extension Study of Onartuzumab in Participants With Solid Tumors on Study Treatment Previously Enrolled in a Company Sponsored StudyHoffmann-La RochePhase 3 Completed12 enrolled 8 charts
NCT00854308 2017-03-31A Study of MetMAb Administered to Patients With Advanced Non-Small Cell Lung Cancer, in Combination With Tarceva (Erlotinib)Genentech, Inc.Phase 2 Completed137 enrolled 11 charts